SEC investigating possible insider trading around Kodak-Trump drug production deal
The Securities and Exchange Commission (SEC) is investigating possible insider trading at Eastman Kodak following a spike in the company’s shares around the announcement of a $765 million government loan to manufacture pharmaceutical ingredients. Sen. Elizabeth Warren had called on the SEC to investigate because shares began rising even before the official announcement of the loan.